Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 9 EP applications Stephen Phillip McNeeney has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 20, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11822219

NEW PROCESS FOR PREPARING CYCLOLIGNANS

IPC classification:
C07D 493/04
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
PATENT GRANTED
EP11825532

POLYMERIC PRODUCT WITH INNER ANTI-MICROBIAL LAYER AND OUTER PROTECTIVE LAYER

IPC classification:
C08K 5/00, C08K 3/00, B32B 27/08, A61L 31/16, A61L 29/16, A61L 27/54
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Agent:
Björn Widén, Brann AB
Status:
GRANT OF PATENT INTENDED
EP12775283

NEW ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE

IPC classification:
A61K 31/485, A61K 9/20, A61K 9/14, A61K 9/00
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
PATENT GRANTED
EP12703125

NOVEL FORMULATIONS FOR DERMAL, TRANSDERMAL AND MUCOSAL USE 1

IPC classification:
A61K 9/70, A61K 47/14, A61K 47/10, A61K 47/06, A61K 9/00
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11831014

PICROPODOPHYLLIN MONOHYDRATE OR POLYMORPH A IN CANCER THERAPY

IPC classification:
A61P 35/00, A61P 27/02, A61P 25/28, A61P 19/02, A61P 17/06, A61P 13/12, A61P 3/10, A61K 31/365
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11729141

USE OF PI3K INIBITORS FOR THE TREATMENT OF OBESITY, STEATOSIS AND AGEING

IPC classification:
A61K 31/5377, C07D 487/04, C07D 471/10, A61K 45/06, A61K 31/4985, A61K 31/35
Applicant:
Centro Nacional de Investigaciones Oncológicas (CNIO)
Agent:
Francisco Javier Sáez Granero, Elzaburu SLP
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP12703537

NOVEL ANTIFUNGAL COMPOSITION

IPC classification:
A61K 31/137, A61K 47/12, A61K 47/10, A61K 31/00, A61K 9/00, A61K 47/18, A61K 31/13
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14725742

A SOLID NANOPARTICLE WITH INORGANIC COATING

IPC classification:
A61K 9/51, A61K 9/50
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Agent:
Brann AB
Status:
GRANT OF PATENT INTENDED
EP11831013

PICROPODOPHYLLIN POLYMORPHS B OR C FOR USE IN CANCER THERAPY

IPC classification:
A61P 35/00, A61P 25/28, A61P 3/10, A61K 31/365, C07D 493/04
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature